Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives - Schedule of Acquisitions and Cost-Reduction/Productivity Initiatives (Detail) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | 27 Months Ended | 33 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 28, 2026 |
Jun. 29, 2025 |
Jun. 28, 2026 |
Jun. 29, 2025 |
Jun. 28, 2026 |
Jun. 28, 2026 |
|||||||||
| Restructuring charges/(credits): | ||||||||||||||
| Employee terminations | $ 354 | $ (148) | $ 369 | $ 236 | ||||||||||
| Asset impairments | 54 | 44 | 82 | 217 | ||||||||||
| Exit costs | 10 | 30 | 17 | 94 | ||||||||||
| Restructuring charges/(credits) | [1] | 419 | (74) | 468 | 547 | |||||||||
| Integration costs and other | [2] | 38 | 56 | 89 | 113 | |||||||||
| Restructuring charges and certain acquisition-related costs | 457 | (18) | 557 | 660 | ||||||||||
| Inventory write-offs––recorded in Cost of sales | 46 | 0 | 46 | 0 | ||||||||||
| Additional depreciation––asset restructuring recorded in Cost of sales | [3] | 10 | 4 | 14 | 7 | |||||||||
| Implementation costs | [4] | 144 | 78 | 233 | 128 | |||||||||
| Total costs associated with acquisitions and cost-reduction/productivity initiatives | 653 | 54 | 848 | 727 | ||||||||||
| Biopharma [Member] | ||||||||||||||
| Restructuring charges/(credits): | ||||||||||||||
| Restructuring charges/(credits) | 390 | (406) | 421 | 211 | ||||||||||
| Biopharma [Member] | Manufacturing Optimization Program [Member] | ||||||||||||||
| Restructuring charges/(credits): | ||||||||||||||
| Restructuring charges/(credits) | (29) | (408) | (52) | (412) | $ 824 | |||||||||
| Biopharma [Member] | Realigning Our Cost Base Program [Member] | ||||||||||||||
| Restructuring charges/(credits): | ||||||||||||||
| Restructuring charges/(credits) | 417 | (25) | 464 | 562 | $ 3,300 | |||||||||
| Income Statement Location [Axis]: us-gaap:CostOfGoodsAndServicesSold | ||||||||||||||
| Restructuring charges/(credits): | ||||||||||||||
| Implementation costs | [4] | 25 | 26 | 40 | 46 | |||||||||
| Income Statement Location [Axis]: us-gaap:OtherNonoperatingIncomeExpense | ||||||||||||||
| Restructuring charges/(credits): | ||||||||||||||
| Net periodic benefit costs/(credits) recorded in Other (income)/deductions––net | (5) | (9) | (2) | (68) | ||||||||||
| Income Statement Location [Axis]: us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | ||||||||||||||
| Restructuring charges/(credits): | ||||||||||||||
| Implementation costs | [4] | 63 | 39 | 102 | 62 | |||||||||
| Income Statement Location [Axis]: us-gaap:SellingGeneralAndAdministrativeExpense | ||||||||||||||
| Restructuring charges/(credits): | ||||||||||||||
| Implementation costs | [4] | $ 56 | $ 14 | $ 91 | $ 20 | |||||||||
| ||||||||||||||